RADIANT4_2A | R Documentation |
Kaplan-Meier digitized data from RADIANT4, figure 2A (PMID 26703889). A reported sample size of 302 for a primary endpoint of PFS in lung/colorectal cancer.
RADIANT4_2A
A data frame of 302 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (everolimus, placebo) | |
Yao JC, Fazio N, Singh S, et al. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. Lancet 2016; 387: 968–77.
summary(RADIANT4_2A)
kmplot(RADIANT4_2A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.